Utility of nintedanib for severe idiopathic pulmonary fibrosis: a single-center retrospective study [Corrigendum]

• Main Authors: Abe M (Author), Tsushima K (Author), Sakayori M (Author), Suzuki K (Author), Ikari J (Author), Terada J (Author), Tatsumi K (Author)
• Format: Book
• Published: Dove Medical Press, 2019-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abe M, Tsushima K, Sakayori M, et al. Drug Des Devel Ther. 2018;12:3369–3375.On page 3372, last paragraph of “Results” section should read from “In Severe Group, patients who were able to continue nintedanib for more than 3 months (n...